Article

Dosage of sugammadex according to the calculated lean body mass in obese female patients: time to reverse moderate neuromuscular blockade induced by rocuronium

DOI: 10.1080/22201181.2019.1571719
Author(s): Cheik Tidiane Hafid Wind-Pouiré BougoumaDepartment of Anaesthesiology and Intensive Care, Burkina Faso, Jean-Luc RJ DemeereDepartment of Anaesthesiology, Belgium

Abstract

Background: Sugammadex is a selective relaxant binding agent for antagonism of prolonged rocuronium-induced neuromuscular blockade. The recommended dose is 2 mg/kg. Based on the pharmacological characteristics of sugammadex in obese patients, the calculated lean body mass (CLBM) should be used to determine the dose to reverse moderate neuromuscular blockade induced by rocuronium.

Get new issue alerts for Southern African Journal of Anaesthesia and Analgesia